Abstract
African-American and Latino/Hispanic persons living with HIV/AIDS are underrepresented in AIDS clinical trials (ACTs). The
aim of this paper was to uncover factors, either unmodifiable or not directly targeted for change, that predicted screening
for ACTs during an efficacious peer-driven intervention (N = 540 total; N = 351 in an intervention arm, N = 189 control). This paper focused on participants assigned to an intervention arm, 56 % of whom were screened for ACTs.
We found a decreased odds of screening was associated with closer proximity to the screening site, gay/lesbian orientation,
lower mental health symptoms, current injection drug use, more recent HIV diagnosis, lack of prior screening experience, and
failure to attend all intervention sessions, but there were no gender or racial/ethnic differences. Efforts to reduce racial/ethnic
disparities in ACTs can be enhanced by attending to these specific factors, which may interfere with programmatic efforts
to increase African-American and Latino/Hispanic representation in ACTs.
aim of this paper was to uncover factors, either unmodifiable or not directly targeted for change, that predicted screening
for ACTs during an efficacious peer-driven intervention (N = 540 total; N = 351 in an intervention arm, N = 189 control). This paper focused on participants assigned to an intervention arm, 56 % of whom were screened for ACTs.
We found a decreased odds of screening was associated with closer proximity to the screening site, gay/lesbian orientation,
lower mental health symptoms, current injection drug use, more recent HIV diagnosis, lack of prior screening experience, and
failure to attend all intervention sessions, but there were no gender or racial/ethnic differences. Efforts to reduce racial/ethnic
disparities in ACTs can be enhanced by attending to these specific factors, which may interfere with programmatic efforts
to increase African-American and Latino/Hispanic representation in ACTs.
- Content Type Journal Article
- Category Original Paper
- Pages 1-12
- DOI 10.1007/s10461-012-0194-1
- Authors
- Marya Gwadz, Center for Drug Use and HIV Research, New York University College of Nursing, 726 Broadway, 10th Floor, New York, NY 10003, USA
- Charles M. Cleland, Center for Drug Use and HIV Research, New York University College of Nursing, 726 Broadway, 10th Floor, New York, NY 10003, USA
- Noelle R. Leonard, Center for Drug Use and HIV Research, New York University College of Nursing, 726 Broadway, 10th Floor, New York, NY 10003, USA
- Amanda S. Ritchie, Center for Drug Use and HIV Research, New York University College of Nursing, 726 Broadway, 10th Floor, New York, NY 10003, USA
- Angela Banfield, Center for Drug Use and HIV Research, New York University College of Nursing, 726 Broadway, 10th Floor, New York, NY 10003, USA
- Marion Riedel, School of Social Work, Columbia University, New York, NY, USA
- Pablo Colon, Center for Drug Use and HIV Research, New York University College of Nursing, 726 Broadway, 10th Floor, New York, NY 10003, USA
- Donna Mildvan, Division of Infectious Diseases, Beth Israel Medical Center, New York, NY, USA
- Journal AIDS and Behavior
- Online ISSN 1573-3254
- Print ISSN 1090-7165